Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells

Staci L. Haney, Cheryl Allen, Michelle L. Varney, Kaitlyn M. Dykstra, Eric R. Falcone, Sean H. Colligan, Qiang Hu, Alyssa M. Aldridge, Dennis L. Wright, Andrew J. Wiemer, Sarah A Holstein

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Tropolones are small organic compounds with metal-directing moieties. Tropolones inhibit the proliferation of cancer cell lines, possibly through their effects on metalloenzymes such as select histone deacetylases (HDACs). Pan-HDAC inhibitors are therapeutically beneficial in the treatment of multiple myeloma, however there is interest in the use of more selective HDAC inhibitor therapy to minimize adverse side effects. We hypothesized that tropolones might have anti-myeloma activities. To this end, a series of novel a-substituted tropolones were evaluated for effects on multiple myeloma cells. While all tested tropolones showed some level of cytotoxicity, MO-OHNap had consistently low IC50 values between 1-11 μM in all three cell lines tested and was used for subsequent experiments. MO-OH-Nap was found to induce apoptosis in a concentration-dependent manner. Time course experiments demonstrated that MO-OH-Nap promotes caspase cleavage in a time frame that was distinct from the pan-HDAC inhibitor suberoylanilide hydroxamic acid (SAHA). Furthermore, MO-OHNap- and SAHA-treated cells possess unique gene expression patterns, suggesting they promote apoptosis via different mechanisms. In particular, MO-OH-Nap increases the expression of markers associated with endoplasmic reticulum stress and the unfolded protein response. Synergistic cytotoxic effects were observed when cells were treated with the combination of MO-OH-Nap and the proteasome inhibitor bortezomib. However, treatment with MO-OH-Nap did not abrogate the bortezomibinduced increase in aggresomes, consistent with an HDAC6-independent mechanism for the observed synergy. Collectively, these finding support further investigation into the usefulness of a-substituted tropolones as anti-myeloma agents.

Original languageEnglish (US)
Pages (from-to)76085-76098
Number of pages14
JournalOncotarget
Volume8
Issue number44
DOIs
StatePublished - Jan 1 2017

Fingerprint

Tropolone
Unfolded Protein Response
Multiple Myeloma
Histone Deacetylases
Apoptosis
Cell Line
Proteasome Inhibitors
Endoplasmic Reticulum Stress
Caspases
Heat-Shock Proteins
Inhibitory Concentration 50
Metals
hydroxide ion
Gene Expression

Keywords

  • Apoptosis
  • Histone deacetylase
  • Myeloma
  • Tropolone
  • Unfolded protein response

ASJC Scopus subject areas

  • Oncology

Cite this

Haney, S. L., Allen, C., Varney, M. L., Dykstra, K. M., Falcone, E. R., Colligan, S. H., ... Holstein, S. A. (2017). Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells. Oncotarget, 8(44), 76085-76098. https://doi.org/10.18632/oncotarget.18543

Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells. / Haney, Staci L.; Allen, Cheryl; Varney, Michelle L.; Dykstra, Kaitlyn M.; Falcone, Eric R.; Colligan, Sean H.; Hu, Qiang; Aldridge, Alyssa M.; Wright, Dennis L.; Wiemer, Andrew J.; Holstein, Sarah A.

In: Oncotarget, Vol. 8, No. 44, 01.01.2017, p. 76085-76098.

Research output: Contribution to journalArticle

Haney, SL, Allen, C, Varney, ML, Dykstra, KM, Falcone, ER, Colligan, SH, Hu, Q, Aldridge, AM, Wright, DL, Wiemer, AJ & Holstein, SA 2017, 'Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells', Oncotarget, vol. 8, no. 44, pp. 76085-76098. https://doi.org/10.18632/oncotarget.18543
Haney SL, Allen C, Varney ML, Dykstra KM, Falcone ER, Colligan SH et al. Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells. Oncotarget. 2017 Jan 1;8(44):76085-76098. https://doi.org/10.18632/oncotarget.18543
Haney, Staci L. ; Allen, Cheryl ; Varney, Michelle L. ; Dykstra, Kaitlyn M. ; Falcone, Eric R. ; Colligan, Sean H. ; Hu, Qiang ; Aldridge, Alyssa M. ; Wright, Dennis L. ; Wiemer, Andrew J. ; Holstein, Sarah A. / Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells. In: Oncotarget. 2017 ; Vol. 8, No. 44. pp. 76085-76098.
@article{ab08cbe6820d472487532db7d140c41f,
title = "Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells",
abstract = "Tropolones are small organic compounds with metal-directing moieties. Tropolones inhibit the proliferation of cancer cell lines, possibly through their effects on metalloenzymes such as select histone deacetylases (HDACs). Pan-HDAC inhibitors are therapeutically beneficial in the treatment of multiple myeloma, however there is interest in the use of more selective HDAC inhibitor therapy to minimize adverse side effects. We hypothesized that tropolones might have anti-myeloma activities. To this end, a series of novel a-substituted tropolones were evaluated for effects on multiple myeloma cells. While all tested tropolones showed some level of cytotoxicity, MO-OHNap had consistently low IC50 values between 1-11 μM in all three cell lines tested and was used for subsequent experiments. MO-OH-Nap was found to induce apoptosis in a concentration-dependent manner. Time course experiments demonstrated that MO-OH-Nap promotes caspase cleavage in a time frame that was distinct from the pan-HDAC inhibitor suberoylanilide hydroxamic acid (SAHA). Furthermore, MO-OHNap- and SAHA-treated cells possess unique gene expression patterns, suggesting they promote apoptosis via different mechanisms. In particular, MO-OH-Nap increases the expression of markers associated with endoplasmic reticulum stress and the unfolded protein response. Synergistic cytotoxic effects were observed when cells were treated with the combination of MO-OH-Nap and the proteasome inhibitor bortezomib. However, treatment with MO-OH-Nap did not abrogate the bortezomibinduced increase in aggresomes, consistent with an HDAC6-independent mechanism for the observed synergy. Collectively, these finding support further investigation into the usefulness of a-substituted tropolones as anti-myeloma agents.",
keywords = "Apoptosis, Histone deacetylase, Myeloma, Tropolone, Unfolded protein response",
author = "Haney, {Staci L.} and Cheryl Allen and Varney, {Michelle L.} and Dykstra, {Kaitlyn M.} and Falcone, {Eric R.} and Colligan, {Sean H.} and Qiang Hu and Aldridge, {Alyssa M.} and Wright, {Dennis L.} and Wiemer, {Andrew J.} and Holstein, {Sarah A}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.18543",
language = "English (US)",
volume = "8",
pages = "76085--76098",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "44",

}

TY - JOUR

T1 - Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells

AU - Haney, Staci L.

AU - Allen, Cheryl

AU - Varney, Michelle L.

AU - Dykstra, Kaitlyn M.

AU - Falcone, Eric R.

AU - Colligan, Sean H.

AU - Hu, Qiang

AU - Aldridge, Alyssa M.

AU - Wright, Dennis L.

AU - Wiemer, Andrew J.

AU - Holstein, Sarah A

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Tropolones are small organic compounds with metal-directing moieties. Tropolones inhibit the proliferation of cancer cell lines, possibly through their effects on metalloenzymes such as select histone deacetylases (HDACs). Pan-HDAC inhibitors are therapeutically beneficial in the treatment of multiple myeloma, however there is interest in the use of more selective HDAC inhibitor therapy to minimize adverse side effects. We hypothesized that tropolones might have anti-myeloma activities. To this end, a series of novel a-substituted tropolones were evaluated for effects on multiple myeloma cells. While all tested tropolones showed some level of cytotoxicity, MO-OHNap had consistently low IC50 values between 1-11 μM in all three cell lines tested and was used for subsequent experiments. MO-OH-Nap was found to induce apoptosis in a concentration-dependent manner. Time course experiments demonstrated that MO-OH-Nap promotes caspase cleavage in a time frame that was distinct from the pan-HDAC inhibitor suberoylanilide hydroxamic acid (SAHA). Furthermore, MO-OHNap- and SAHA-treated cells possess unique gene expression patterns, suggesting they promote apoptosis via different mechanisms. In particular, MO-OH-Nap increases the expression of markers associated with endoplasmic reticulum stress and the unfolded protein response. Synergistic cytotoxic effects were observed when cells were treated with the combination of MO-OH-Nap and the proteasome inhibitor bortezomib. However, treatment with MO-OH-Nap did not abrogate the bortezomibinduced increase in aggresomes, consistent with an HDAC6-independent mechanism for the observed synergy. Collectively, these finding support further investigation into the usefulness of a-substituted tropolones as anti-myeloma agents.

AB - Tropolones are small organic compounds with metal-directing moieties. Tropolones inhibit the proliferation of cancer cell lines, possibly through their effects on metalloenzymes such as select histone deacetylases (HDACs). Pan-HDAC inhibitors are therapeutically beneficial in the treatment of multiple myeloma, however there is interest in the use of more selective HDAC inhibitor therapy to minimize adverse side effects. We hypothesized that tropolones might have anti-myeloma activities. To this end, a series of novel a-substituted tropolones were evaluated for effects on multiple myeloma cells. While all tested tropolones showed some level of cytotoxicity, MO-OHNap had consistently low IC50 values between 1-11 μM in all three cell lines tested and was used for subsequent experiments. MO-OH-Nap was found to induce apoptosis in a concentration-dependent manner. Time course experiments demonstrated that MO-OH-Nap promotes caspase cleavage in a time frame that was distinct from the pan-HDAC inhibitor suberoylanilide hydroxamic acid (SAHA). Furthermore, MO-OHNap- and SAHA-treated cells possess unique gene expression patterns, suggesting they promote apoptosis via different mechanisms. In particular, MO-OH-Nap increases the expression of markers associated with endoplasmic reticulum stress and the unfolded protein response. Synergistic cytotoxic effects were observed when cells were treated with the combination of MO-OH-Nap and the proteasome inhibitor bortezomib. However, treatment with MO-OH-Nap did not abrogate the bortezomibinduced increase in aggresomes, consistent with an HDAC6-independent mechanism for the observed synergy. Collectively, these finding support further investigation into the usefulness of a-substituted tropolones as anti-myeloma agents.

KW - Apoptosis

KW - Histone deacetylase

KW - Myeloma

KW - Tropolone

KW - Unfolded protein response

UR - http://www.scopus.com/inward/record.url?scp=85030326746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030326746&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.18543

DO - 10.18632/oncotarget.18543

M3 - Article

C2 - 29100294

AN - SCOPUS:85030326746

VL - 8

SP - 76085

EP - 76098

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 44

ER -